Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls

European Journal of Neurology

Volumn 23, Issue 4, 2016, Pages 817-822

  Granberg, T ^a,b   Hashim, F ^a,b   Andersen, O ^c   Sundal, C ^c,d   Karrenbauer, V D ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

CSF1R; Hereditary diffuse leukoencephalopathy with spheroids; MRI; Multiple sclerosis; Volumetry

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN SIZE; CEREBELLUM ATROPHY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GRAY MATTER; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH SPHEROID; HUMAN; HUMAN TISSUE; IMAGING SOFTWARE; LEUKOENCEPHALOPATHY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; VOLUMETRY; WHITE MATTER; ATROPHY; BRAIN; CEREBELLUM; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; PATHOLOGY;

ADULT; ATROPHY; BRAIN; CEREBELLUM; CROSS-SECTIONAL STUDIES; FEMALE; GRAY MATTER; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; WHITE MATTER;

EID: 84954289637     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12948     Document Type: Article

References (27)

1. Axelsson R, Röyttä M, Sourander P, Akesson HO, Andersen O. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand 1984; 314: 1-65.
2. Baba Y, Ghetti B, Baker MC, et al. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 2006; 111: 300-311.
3. Freeman SH, Hyman BT, Sims KB, et al. Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol 2009; 19: 39-47.
4. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012; 44: 200-205.
5. Guerreiro R, Kara E, Le Ber I, et al. Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA 2013; 70: 875-882.
6. Yamashita M, Yamamoto T. Neuroaxonal leukoencephalopathy with axonal spheroids. Eur Neurol 2002; 48: 20-25.
7. Mendes A, Pinto M, Vieira S, Castro L, Carpenter S. Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci 2010; 297: 40-45.
8. Karle KN, Biskup S, Schüle R, et al. De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology 2013; 81: 2039-2044.
9. Sundal C, Lash J, Aasly J, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012; 314: 130-137.
10. Konno T, Tada M, Tada M, et al. Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. Neurology 2014; 82: 139-148.
11. Sundal C, Baker M, Karrenbauer V, et al. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur J Neurol 2015; 22: 328-333.
12. Sundal C, Van Gerpen JA, Nicholson AM, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 2012; 79: 566-574.
13. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 2008; 71: 925-929.
14. Boissé L, Islam O, Woulfe J, Ludwin SK, Brunet DG. Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings. J Neurol Neurosurg Psychiatry 2010; 81: 313-314.
15. Battisti C, Di Donato I, Bianchi S, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids: three patients with stroke-like presentation carrying new mutations in the CSF1R gene. J Neurol 2014; 261: 768-772.
16. Bender B, Klose U, Lindig T, et al. Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). J Neurol 2014; 261: 2351-2359.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444.
18. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
19. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage 2012; 61: 1402-1418.
20. Ashburner J, Friston KJ. Unified segmentation. NeuroImage 2005; 26: 839-851.
21. Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. NeuroImage 2012; 59: 3774-3783.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289-300.
23. Hoffmann S, Murrell J, Harms L, et al. Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol 2014; 24: 452-458.
24. Riku Y, Ando T, Goto Y, et al. Early pathologic changes in hereditary diffuse leukoencephalopathy with spheroids. J Neuropathol Exp Neurol 2014; 73: 1183-1190.
25. Kinoshita M, Kondo Y, Yoshida K, et al. Corpus callosum atrophy in patients with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: an MRI-based study. Intern Med 2014; 53: 21-27.
26. Granberg T, Martola J, Bergendal G, et al. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: results of a 17-year longitudinal study. Mult Scler 2008; 21: 1151-1158.
27. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008; 7: 615-625.